comparemela.com

Latest Breaking News On - ஆஷ்ஃபீல்ட் மருந்தியல் - Page 1 : comparemela.com

Ergomed Plc sees earnings ahead of expectations as it highlights strong start to 2021

Ergomed buys up cancer, rare disease CRO MedSource

(miroslav 1/Getty) Britain-based biopharma services company Ergomed has snapped up U.S. contract research organization MedSource to boost its offerings and geographic footprint. Ergomed will add the Houston-based CRO into its business, boosting its rare disease and oncology services, as well around $20 million a year in contracts and revenue, with more than $41 million in order book future revenue, and new clients. The deal, financials of which were not made public, will also “further accelerate Ergomed’s growth in the North American market,” according to a statement, with offices in Houston, Boston and Raleigh, North Carolina, in the U.S. and Newcastle upon Tyne in the U.K.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.